Kanabo Group Plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KNB.L research report →
Companywww.kanabogroup.com
Kanabo Group Plc develops and distributes cannabis-derived products for medical patients. It also offers non- tetrahydrocannabinol products for cannabidiol consumers. The company offers its products under the Kanabo brand name.
- CEO
- Avihu Tamir
- IPO
- 2017
- Employees
- 20
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $1.42M
- P/E
- -0.15
- P/S
- 1.59
- P/B
- 0.16
- EV/EBITDA
- -0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 14.97%
- Op Margin
- -870.73%
- Net Margin
- -892.40%
- ROE
- -80.03%
- ROIC
- -100.24%
Growth & Income
- Revenue
- $895.00K · 48.42%
- Net Income
- $-7,987,000 · 0.13%
- EPS
- $-0.01 · 22.80%
- Op Income
- $-7,793,000
- FCF YoY
- 22.37%
Performance & Tape
- 52W High
- $2.00
- 52W Low
- $0.15
- 50D MA
- $0.68
- 200D MA
- $0.99
- Beta
- 2.30
- Avg Volume
- 492.01K
Get TickerSpark's AI analysis on KNB.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KNB.L Coverage
We haven't published any research on KNB.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KNB.L Report →